Chemoinformaics analysis of 8-alpha-11-Elemodiol
| Molecular Weight | 222.372 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 12 |
| Exact Molecular Weight | 222.198 | nRing | 2 |
| Solubility: LogS | -4.056 | nHRing | 0 |
| Solubility: LogP | 4.461 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.618 |
| Synth | 4.602 |
| Natural Product Likeliness | 3.151 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.01 |
| CACO-2 | -4.486 |
| MDCK | 0.0000171 |
| BBB | 0.747 |
| PPB | 0.951496 |
| VDSS | 1.723 |
| FU | 0.0417701 |
| CYP1A2-inh | 0.177 |
| CYP1A2-sub | 0.547 |
| CYP2c19-inh | 0.101 |
| CYP2c19-sub | 0.886 |
| CYP2c9-inh | 0.279 |
| CYP2c9-sub | 0.894 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.719 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.309 |
| CL | 14.512 |
| T12 | 0.09 |
| hERG | 0.027 |
| Ames | 0.011 |
| ROA | 0.033 |
| SkinSen | 0.409 |
| Carcinogencity | 0.059 |
| EI | 0.176 |
| Respiratory | 0.455 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.882275 |